Frequency Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Korro Bio

10/08/2023 22:03

* Frequency Therapeutics Inc  FREQ.OQ  reported a quarterly
adjusted loss of 30 cents​​ per share for the quarter ended in
June. The mean expectation of four analysts for the quarter was
for a loss of 36 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Frequency Therapeutics Inc's reported EPS for the quarter
was a
loss of 30 cents​.
    * The mean earnings estimate of analysts had fallen by
about 6.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Frequency Therapeutics Inc shares had risen by 105.2% this
quarter and lost 81.6% so far this year.
    * The company reported a quarterly loss of $10.8 million.
    * Wall Street's median 12-month price target for Frequency
Therapeutics Inc is $4.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 10 at 09:03 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.36          -0.30          Beat
 Mar. 31 2023      -0.42          -0.55          Missed
 Dec. 31 2022      -0.63          -0.49          Beat
 Sep. 30 2022      -0.57          -0.55          Beat